Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Established Atherosclerotic Cardiovascular Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06541691
What this trial is testing

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

Who this might be right for
Atherosclerotic Cardiovascular DiseaseCoronary Artery DiseaseIschemic Heart Disease+4 more
Rajaie Cardiovascular Medical and Research Center 3,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05030428
What this trial is testing

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 17,004
Large-scale testing (Phase 3)Study completedNCT06267560
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 422
Large-scale testing (Phase 3)Active Not RecruitingNCT01252953
What this trial is testing

REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification

Who this might be right for
Atherosclerotic Cardiovascular Disease
University of Oxford 30,449
Testing effectiveness (Phase 2)Study completedNCT00633022
What this trial is testing

Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

Who this might be right for
Atherosclerosis
GlaxoSmithKline 99
Not applicableLooking for participantsNCT06871514
What this trial is testing

Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular DiseasesShared-decision Making
dr.Frank L.J. Visseren 1,200
Not applicableWithdrawnNCT05566678
What this trial is testing

Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease

Who this might be right for
Cardiovascular DiseasesSmokingTobacco Use+2 more
Philip Morris Products S.A.
Not applicableActive Not RecruitingNCT06295679
What this trial is testing

A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Who this might be right for
Major Cardiovascular EventEstablished Atherosclerotic Cardiovascular Disease
Amgen 7,000
Not applicableStudy completedNCT03232099
What this trial is testing

Red Wine Effects Upon Gut Flora and Plasma Levels of Trimethylamine-N-oxide (TMAO) - WineFlora Study

Who this might be right for
Trimethylamine-N-oxideGut MicrobiotaEffects of Red Wine+1 more
University of Sao Paulo General Hospital 42
Not applicableStudy completedNCT03172507
What this trial is testing

The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases

Who this might be right for
AtherosclerosisCardiovascular Diseases
Radboud University Medical Center 27
Early research (Phase 1)Study completedNCT06675175
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.

Who this might be right for
Chronic Kidney DiseaseAtherosclerotic Cardiovascular Disease
AstraZeneca 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT06587737
What this trial is testing

Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

Who this might be right for
ColchicineICH - Intracerebral HemorrhageStroke+1 more
Population Health Research Institute 1,125
Not applicableStudy completedNCT05009602
What this trial is testing

Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes

Who this might be right for
Diabetic FootPeripheral Arterial DiseaseDiabetic Foot Ulcer+4 more
Imperial College London 604
Large-scale testing (Phase 3)Looking for participantsNCT07613294
What this trial is testing

See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Who this might be right for
AtherosclerosisCardiovascular DiseasesLipoprotein(a)
Eli Lilly and Company 252
Large-scale testing (Phase 3)Study completedNCT01732822
What this trial is testing

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Who this might be right for
Peripheral Artery Disease
AstraZeneca 13,885
Large-scale testing (Phase 3)Looking for participantsNCT06875973
What this trial is testing

Pelacarsen Roll-over Extension Program

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 599
Not applicableStudy completedNCT04545879
What this trial is testing

Investigating the Gut Microbiota Modulation Effects of Allicin for Cardiovascular Disease Protection and Establishing Microbiota Directed Personalized Nutrition Guidance With Novel Humanized Gnotobiotic Mice Model, Microbial Culturomics and Metabolomic Technique

Who this might be right for
Atherosclerosis
National Taiwan University Hospital 9
Large-scale testing (Phase 3)Study completedNCT05610280
What this trial is testing

Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

Who this might be right for
HypertriglyceridemiaCardiovascular DiseasesAtherosclerosis
Ionis Pharmaceuticals, Inc. 1,478
Large-scale testing (Phase 3)Active Not RecruitingNCT06292013
What this trial is testing

Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company 17,300
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Next Page